(AOF) – ABC Arbitrage
ABC Arbitrage was informed by letter on November 24, 2021 of the sale of all ABC arbitrage securities held by IPA on November 22, 2021. These securities (367,763 shares) were sold to the company Financière WDD through a block transaction at market price, ie 7.085 euros. The acquisition of all ABC Arbitrage securities held by IPA by WDD Financial has in practice no impact on the capital allocation of ABC Arbitrage, the investment company said.
Carbios
Carbios, alongside its partners T.EN Zimmer GmbH and Deloitte, obtained European funding of 3.3 million euros (including 3 million euros for Carbios) in the form of a subsidy. T.EN Zimmer GmbH brings its expertise on the repolymerization of 100% recycled PET monomers and Deloitte on the analysis of the environmental performance (in particular via the Life Cycle Analysis) of the process from plastic and textile waste.
Gaussin
Gaussin announced an exclusive 20-year production and licensing agreement with Nexport, an Australian producer and supplier of electric vehicles. This contract follows the signing of the modalities agreement last September. The 20-year joint venture and license agreement provides for the assembly and local supply of Gaussin’s range of zero-emission vehicles and systems for port terminals, airports, logistics and passenger transport applications.
Laurent Perrier
Laurent-Perrier has published half-year results for 2021-2022, showing strong growth thanks to the gradual lifting of health measures and the gradual reopening of places of consumption around the world. Over the six-month period ended at the end of September, the Champagne House achieved a net profit of 23.3 million euros, up 207.2%. Compared to the first half of 2019-2020, i.e. before the pandemic, the increase reached 112.4%. Operating income jumped 144.9% to 35.6 million, showing a margin of 27.8%, up 7.3 points.
Miliboo
Miliboo achieved in the second quarter of 2021 ended at the end of October a turnover up 4.3% to 9.441 million euros. Sales of the digital furniture brand rebounded after the 2.8% decline in the first quarter. In France (87% of turnover), sales climbed 5.3%. They were driven in particular by the good performance of the activity in the shops. International revenue was down 1.7%, still impacted by the strategic end of sales in the United Kingdom and Switzerland.
Novacyt
Novacyt’s genesig Covid-19 real-time PCR test has been approved in the UK. This test is the first from medtech to be added to the British Medical Device Safety Agency (CTDA) register. Novacyt will now work on resuming sales of the product in the UK. The genesig test was launched on January 31, 2020 and was one of the world’s first tests available on the market.
Quantum Genomics
Quantum Genomics announced the signing of an exclusive license agreement with Teva Israel Ltd. – subsidiary of Teva Pharmaceutical Industries Ltd – to market firibastat in Israel. Teva will receive exclusive marketing rights for its historic market in the resistant and difficult-to-treat hypertension indication. The French biopharmaceutical company will receive payments of up to $ 11 million as well as royalties ranging from 25% up to 30% on future sales of firibastat.
Receive our latest news
Every morning, the information to remember about financial markets.